Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Strong Performer, Getting Expensive
Download real time
2116.30
64.40
(
3.14
%)
65.92% Gain from 52W Low
1.3M
NSE+BSE Volume
NSE
09 Sep, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Dividend
Glenmark Pharmaceuticals Ltd. has an upcoming dividend of ₹2.50 per share due on 15 Sep 2025
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd. Corporate Filings & Announcements
Latest corporate announcements and filings from Glenmark Pharmaceuticals Ltd. on BSE
Get corporate announcements alerts
Hourly Digest
Daily Digest
All
News
Earnings Calls
Corporate Announcements
Research Reports
Load latest
Is Glenmark Pharmaceuticals Ltd. worth buying?
571 Votes:
Buy
79.33%
Sell
13.66%
Hold
7.01%
BUY
SELL
HOLD
RESEARCH REPORTS
Accumulate
SEE REPORTS >
09 Sep 2025, 12:00AM
pdf
Glenmark Pharmaceuti..
by Geojit BNP Paribas
| Target:
2306
| Upside:
8.96%
Buy
SEE REPORTS >
02 Sep 2025
pdf
Glenmark Pharmaceuti..
by Deven Choksey
| Target:
2300
| Upside:
8.68%
All reports of GLENMARK